What is Wegovy?
Wegovy is an injectable semaglutide product with Canadian authorization for chronic weight management in eligible adults and adolescents. Its product information sets out the exact criteria and other authorized uses; treatment requires assessment by a prescriber.
How is Wegovy different from Ozempic?
The shared ingredient does not make Wegovy and Ozempic identical prescriptions. Compare the authorized product, presentation and full cost. Sevmia’s approval specifically references Wegovy.
What does Sevmia’s approval mean?
Health Canada announced Sevmia, a Wegovy-referencing generic, on June 29, 2026. That approval does not establish availability at your pharmacy.
Read the update →Before you fill your prescription
Wegovy and Ozempic share an ingredient, but their product instructions and approved uses are not interchangeable. Use the specific Canadian product record for a comparison.
Ask your pharmacy for a quote showing the exact DIN, package, days supplied, dispensing fee and delivery. If you use an online provider, check visit and membership charges separately.
For insurance, confirm the exact DIN, any prior authorization and your remaining deductible or limits with your plan.
Check coverage steps →Product sources and review details
Sources reviewed 2026-09-20. Check the current Canadian product information with your pharmacist for dosing and safety questions.
Wegovy product source
Clarity in every comparison.